Correlation Between Pfizer and GeneDx Holdings

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pfizer and GeneDx Holdings at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and GeneDx Holdings into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and GeneDx Holdings Corp, you can compare the effects of market volatilities on Pfizer and GeneDx Holdings and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of GeneDx Holdings. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and GeneDx Holdings.

Diversification Opportunities for Pfizer and GeneDx Holdings

-0.66
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Pfizer and GeneDx is -0.66. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and GeneDx Holdings Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on GeneDx Holdings Corp and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with GeneDx Holdings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of GeneDx Holdings Corp has no effect on the direction of Pfizer i.e., Pfizer and GeneDx Holdings go up and down completely randomly.

Pair Corralation between Pfizer and GeneDx Holdings

Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the GeneDx Holdings. But the stock apears to be less risky and, when comparing its historical volatility, Pfizer Inc is 4.65 times less risky than GeneDx Holdings. The stock trades about -0.05 of its potential returns per unit of risk. The GeneDx Holdings Corp is currently generating about 0.19 of returns per unit of risk over similar time horizon. If you would invest  2,145  in GeneDx Holdings Corp on August 30, 2024 and sell it today you would earn a total of  5,798  from holding GeneDx Holdings Corp or generate 270.3% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Pfizer Inc  vs.  GeneDx Holdings Corp

 Performance 
       Timeline  
Pfizer Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's technical and fundamental indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.
GeneDx Holdings Corp 

Risk-Adjusted Performance

17 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in GeneDx Holdings Corp are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak technical and fundamental indicators, GeneDx Holdings unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pfizer and GeneDx Holdings Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pfizer and GeneDx Holdings

The main advantage of trading using opposite Pfizer and GeneDx Holdings positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, GeneDx Holdings can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in GeneDx Holdings will offset losses from the drop in GeneDx Holdings' long position.
The idea behind Pfizer Inc and GeneDx Holdings Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Other Complementary Tools

Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules